The Venture Codex Logo

The Venture Codex

Advent France Biotechnology

4 Rue Thénard, Paris, Ile-de-France, 75005, France

Overview

European venture capital firm focused on Life Sciences and biotechnology.

Founded

2016

Deals · 12mo

1

Links

WebsiteLinkedIn

Stage focus

Seed
Series A

Geographic focus

Belgium
France
Spain

Sector focus

—

Investment portfolio

20rounds
NAMEDATESIZE
Tenpoint Therapeutics
Jan 2026Participated
$235 MDebt
ARTHEx Biotech
Sep 2025Participated
$87 MSeries B
Integra Therapeutics
Sep 2025Participated
$13 MSeries A
Augustine Therapeutics
Mar 2025Participated
$91 MSeries A
Augustine Therapeutics
Jun 2024Participated
$18 MSeries A
Orikine Bio
Jul 2023Led
$6 MSeed
Astraveus
Jun 2023Led
$18 MSeed
DiogenX
May 2023Participated
$30 MSeries A
Tridek-One
Sep 2022Participated
$16 MOther Equity
Integra Therapeutics
Dec 2021Participated
$5 MSeed
Aglaia Oncology Funds
Sep 2021Led
$5 MSeed
AgomAb Therapeutics
Mar 2021Participated
$74 MSeries B
Tenpoint Therapeutics
Jan 2026Participated
$235 MDebt
ARTHEx Biotech
Sep 2025Participated
$87 MSeries B
Integra Therapeutics
Sep 2025Participated
$13 MSeries A
Augustine Therapeutics
Mar 2025Participated
$91 MSeries A
Augustine Therapeutics
Jun 2024Participated
$18 MSeries A
Orikine Bio
Jul 2023Led
$6 MSeed
Astraveus
Jun 2023Led
$18 MSeed
DiogenX
May 2023Participated
$30 MSeries A
Tridek-One
Sep 2022Participated
$16 MOther Equity
Integra Therapeutics
Dec 2021Participated
$5 MSeed
Aglaia Oncology Funds
Sep 2021Led
$5 MSeed
AgomAb Therapeutics
Mar 2021Participated
$74 MSeries B
20
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Advent France Biotechnology: 20 funding rounds are recorded in the selected participation categories.All available history.
Advent France Biotechnology: 20 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed43
Series A15
Series B02
Other Equity22
Debt01

Monthly Deal Activity

Advent France Biotechnology: 20 deals are recorded across 91 months.All available history.
Advent France Biotechnology: 20 deals are recorded across 91 months. All available history
MonthDeals
Apr '191
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '191
Dec '191
Jan '201
Feb '200
Mar '201
Apr '200
May '200
Jun '201
Jul '202
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '211
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '211
Oct '210
Nov '210
Dec '211
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '221
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '231
Jun '231
Jul '231
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '241
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '251
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '252
Oct '250
Nov '250
Dec '250
Jan '261
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Advent France Biotechnology: Health & Life Sciences is the largest displayed sector by deal count (20 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Advent France Biotechnology: Health & Life Sciences is the largest displayed sector by deal count (20 deals). All available history
SectorDeals
Health & Life Sciences20
Consumer & Lifestyle2
Networks, Cloud & Communication1
Fintech1
Space & Frontier Tech1

Deal Size Distribution

Advent France Biotechnology: 20 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Advent France Biotechnology: 20 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M6
$5M-$10M3
$10M-$25M6
$25M-$50M1
$50M-$100M3
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Advent France Biotechnology: Europe has the largest recorded deal count among the displayed regions (19 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Advent France Biotechnology: Europe has the largest recorded deal count among the displayed regions (19 deals). All available history
RegionDeals
Europe19
546801
Advent France Biotechnology: 20 co-investors are shown, with Invivo Capital sharing 5 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Advent France Biotechnology: 20 co-investors are shown, with Invivo Capital sharing 5 recorded deals. All available history
Co-investorShared deals
Invivo Capital5
V-Bio Ventures5
Asabys Partners3
Boehringer Ingelheim3
Eli Lilly and Company3
Gemma Frisius Fund3
Omnes Capital3
PMV3
Bpifrance2
Charcot-Marie Tooth Research Foundation2
Columbus Venture Partners2
JDRF2
Pontifax2
Takeda Ventures2
VIB2
Advent Life Sciences1
Andera Partners1
Bioqube Ventures1
Boehringer Ingelheim Venture Fund1
Bpifrance Large Venture1

Investment Strategy

Advent France Biotechnology: Led accounts for 35% and participating for 65% of round participation.All available history.
Advent France Biotechnology: Led accounts for 35% and participating for 65% of round participation. All available history
CategoryDeals (count)Share (%)
Led735%
Participating1365%
Advent France Biotechnology: Single-lead accounts for 29% and co-led for 71% of lead dynamics.All available history.
Advent France Biotechnology: Single-lead accounts for 29% and co-led for 71% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead229%
Co-led571%

Team

Alain Huriez

President & General Partner

Arnaud Foussat

Operating Partner

Francesc Dosrius

Investment Analyst

Jeremie Mariau

Operating Partner

Matthieu Coutet

Managing Partner

Sidonie Fabre

CFO